BRIEF published on 04/28/2026 at 22:05, 12 days 7 hours ago FORVIA lance un programme de rachat d'actions Rachat D'actions Technologie Automobile Confiance Du Marché Forvia Primes De Performance
BRIEF published on 04/28/2026 at 22:00, 12 days 7 hours ago Piramal Pharma Limited Reports FY26 Financial Results Strategic Investment Revenue Decline Segment Growth Piramal Pharma Limited Financial Results 2026
BRIEF published on 04/28/2026 at 22:00, 12 days 7 hours ago Piramal Pharma Limited publie ses résultats financiers pour l'exercice 2026 Investissement Stratégique Baisse Des Revenus Croissance Du Segment Piramal Pharma Limited Résultats Financiers 2026
BRIEF published on 04/28/2026 at 21:05, 12 days 8 hours ago VAT Group AG Shareholders Approve Board Proposals and 12% Dividend Increase Dividend Increase VAT Group AG Shareholder Resolutions Board Re-elections AGM 2026
BRIEF published on 04/28/2026 at 21:05, 12 days 8 hours ago Les actionnaires de VAT Group AG approuvent les propositions du conseil d'administration et une augmentation de 12 % du dividende. Réélections Du Conseil D'administration Résolutions Des Actionnaires Augmentation Des Dividendes Groupe TVA AG Assemblée Générale Annuelle 2026
BRIEF published on 04/28/2026 at 20:40, 12 days 8 hours ago GenSight Biologics annonce son Assemblée Générale Mixte de 2026 Actionnaires Assemblée Générale Documents Préparatoires Thérapie Génique GenSight Biologics
BRIEF published on 04/28/2026 at 20:40, 12 days 8 hours ago GenSight Biologics Schedules Annual General Meeting for May 2026 Annual General Meeting Regulatory Compliance Shareholder Information Investor Relations Gene Therapy
BRIEF published on 04/28/2026 at 20:40, 12 days 8 hours ago GenSight Biologics announces its 2026 Combined General Meeting Shareholders Gene Therapy General Assembly Preparatory Documents GenSight Biologics
BRIEF published on 04/28/2026 at 20:40, 12 days 8 hours ago GenSight Biologics programme son assemblée générale annuelle pour mai 2026 Conformité Réglementaire Assemblée Générale Annuelle Thérapie Génique Relations Avec Les Investisseurs Informations Destinées Aux Actionnaires
BRIEF published on 04/28/2026 at 20:05, 12 days 9 hours ago Mise à disposition du rapport financier annuel 2025 de Bogart AMF Rapport Financier Commissaires Aux Comptes Jacques Bogart Exercice 2025
Published on 05/09/2026 at 01:30, 2 days 3 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 2 days 5 hours ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/10/2026 at 16:05, 13 hours 22 minutes ago RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
Published on 05/10/2026 at 14:00, 15 hours 27 minutes ago MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 17 hours 42 minutes ago Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 1 day 10 hours ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 2 days 8 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/07/2026 at 19:15, 3 days 10 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 10 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 days 10 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 days 10 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 3 days 10 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
